MENU
ERAS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Erasca (ERAS) Earnings Date & Reports
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more
A.I. Advisor
published Earnings
ERAS is expected to report earnings to -14 cents per share on November 11
Q3'26
Est.
$-0.14
Q2'26
Missed
by $0.03
Q1'26
Missed
by $0.49
Q4'25
Beat
by $0.01
Q3'25
Missed
by $0.01
The last earnings report on August 11 showed earnings per share of -14 cents, missing the estimate of -10 cents. With 18.25K shares outstanding, the current market capitalization sits at 5.12B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
3115 Merryfield Row
Phone
+1 858 465-6511
Employees
103
Web
https://www.erasca.com